NASDAQ:NBIX - Neurocrine Biosciences Earnings Date, Estimates & History Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $79.91 -0.92 (-1.14 %) (As of 06/27/2019 04:10 AM ET) Add Compare Today's Range$79.06Now: $79.91▼$81.2150-Day Range$74.65MA: $81.56▼$86.6252-Week Range$64.72Now: $79.91▼$126.98Volume671,077 shsAverage Volume897,995 shsMarket Capitalization$7.29 billionP/E Ratio363.23Dividend YieldN/ABeta1.46 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Earnings Neurocrine Biosciences (NASDAQ:NBIX) Earnings History and Estimates ChartNeurocrine Biosciences (NASDAQ:NBIX) Earnings Estimates2019 EPS Consensus Estimate: ($0.02)2020 EPS Consensus Estimate: $3.15QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20194($1.39)($0.13)($0.92)Q2 20194$0.02$0.42$0.25Q3 20194$0.28$0.41$0.35Q4 20194$0.22$0.38$0.30Q1 20201$0.41$0.41$0.41Q2 20201$0.65$0.65$0.65Q3 20201$0.90$0.90$0.90Q4 20201$1.19$1.19$1.19Neurocrine Biosciences (NASDAQ NBIX) Earnings History by QuarterDateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails7/30/2019(Estimated) 4/29/20193/31/2019($1.05)($1.12)($1.12)$136.77 million$138.40 millionViewListen2/5/201912/31/2018$0.14$0.19$0.19$132.32 million$131.49 millionViewN/A11/5/20189/30/2018$0.48$0.52$0.52$151.51 million$151.80 millionViewListen7/31/2018Q2 2018($0.18)($0.07)($0.07)$84.11 million$96.90 millionViewN/A4/30/2018Q1 2018($0.29)($0.47)($0.47)$65.17 million$71.08 millionViewListen2/13/2018Q4 2017$0.18$0.07$0.07$94.00 million$94.52 millionViewListen11/1/2017Q3 2017($0.49)($0.13)($0.13)$29.38 million$60.77 millionViewN/A8/3/2017Q2 17($0.67)($0.68)($0.68)$0.61 million$6.34 millionViewListen5/9/2017Q1 17($0.67)($0.90)($0.90)$3.00 millionViewListen2/14/2017Q416($0.55)($0.51)($0.51)$4.55 millionViewListen11/2/2016Q316($0.57)($0.43)($0.43)ViewN/A8/3/2016Q2 2016($0.50)($0.46)($0.46)ViewN/A5/5/2016Q1($0.29)($0.22)($0.22)$15.43 million$15.00 millionViewN/A2/11/2016Q415($0.32)($0.34)($0.34)$3.33 millionViewListen10/29/2015Q315($0.25)($0.40)($0.40)$6.66 millionViewListen7/29/2015Q2($0.2860)($0.28)($0.28)$0.41 millionViewListen4/30/2015Q115($0.30)($0.01)($0.01)$19.76 millionViewN/A2/9/2015Q414($0.24)($0.26)($0.26)ViewN/A11/3/2014Q314($0.21)($0.21)($0.21)ViewN/A8/6/2014Q214($0.18)($0.18)($0.18)$0.12 millionViewN/A4/30/2014Q114($0.19)($0.17)($0.17)$0.78 millionViewN/A2/6/2014Q4 2013($0.17)($0.16)($0.16)$0.79 million$0.73 millionViewN/A10/29/2013Q3 2013($0.20)($0.17)($0.17)$0.79 million$0.73 millionViewN/A7/25/2013Q2 2013($0.20)($0.18)($0.18)$0.77 million$0.73 millionViewListen5/2/2013Q1 2013($0.18)($0.18)($0.18)$1.07 million$0.70 millionViewListen2/8/2013Q4 2012($0.08)$0.14$9.43 million$21.90 millionViewListen10/31/2012Q312($0.05)($0.05)$10.28 million$9.40 millionViewN/A7/31/2012($0.03)($0.01)ViewN/A5/2/2012($0.01)ViewN/A2/8/2012Q4 2011$0.01$0.02$0.02ViewN/A10/31/2011$0.19$0.56ViewN/A7/28/2011$0.04$0.04ViewN/A5/3/2011$0.05$0.05ViewN/A2/10/2011$0.04$0.05ViewN/A10/28/2010Q3 2010$0.05$0.06$0.06ViewN/A7/28/2010Q2 2010($0.17)($0.09)($0.09)ViewN/A4/28/2010Q1 2010($0.24)($0.20)($0.21)ViewN/A2/3/2010Q4 2009($0.28)($0.22)($0.24)ViewN/A10/28/2009Q3 2009($0.35)($0.21)($0.21)ViewN/A7/29/2009Q2 2009($0.41)($0.37)($0.35)ViewN/A5/5/2009Q1 2009($0.38)($0.38)($0.25)ViewN/A2/3/2009Q4 2008($0.47)($0.75)($0.75)ViewN/A10/28/2008Q3 2008($0.52)($0.46)($0.46)ViewN/A7/30/2008Q2 2008($0.52)($0.55)($0.55)ViewN/A4/30/2008Q1 2008($0.54)($0.55)($0.55)ViewN/A2/5/2008Q4 2007($0.84)($0.71)$1.93ViewN/A(Earnings results data provided by Zacks Investment Research) This page was last updated on 6/27/2019 by MarketBeat.com StaffFeatured Article: Why are analyst ratings important in trading stocks?
